Although oral phosphodiesterase 5 inhibitors have substantially improved the treatment of erectile dysfunction, unmet needs among men with erectile dysfunction still exist. This article considers the possibility of gene therapy for these patients, and discusses results from early clinical studies of gene therapy for erectile dysfunction.
